Influenza and Other Respiratory Viruses · 2024 · 25 citations · 12 references
Public HealthInfectious DiseasesPediatricsInfectious Disease EpidemiologyPediatric EpidemiologyPediatric Infectious DiseasesChild Health EpidemiologyInfant Infectious DiseasesInfectious Disease PreventionInfectious Disease SurveillanceRespiratory Disease Epidemiology In ChildrenRespiratory Infectious DiseasesChildhood Infectious Disease PreventionChildhood Respiratory Syncytial Virus EpidemiologyPediatric SurveillanceRespiratory Infection EpidemiologyRespiratory Infections In ChildrenSentinel Surveillance NetworksSentinel Surveillance SystemsSevere Acute Respiratory Syndrome
BACKGROUND: Data from the sentinel surveillance system of severe acute respiratory infections in Spain were used to estimate the impact of administration of nirsevimab to children born from 1 April 2023 onwards. METHODS: Estimated RSV hospitalisations in < 1-year-olds during weeks 40, 2023, to 8, 2024, were compared to the number that would be expected after accounting for the background change in RSV circulation in the 2023/24 season, compared to 2022/23. RESULTS: We estimated 9364-9875 RSV hospitalisations less than expected, corresponding to a 74%-75% reduction.
12
Eric A. F. Simões, Shabir A. Madhi, William J. Muller et al. · The Lancet Child & Adolescent Health · 2023 · 318 citations · Full text
Mónica López‐Lacort, Cintia Muñoz-Quiles, Ainara Mira‐Iglesias et al. · Eurosurveillance · 2024 · 174 citations · Full text